Baxter 2021 Corporate Responsibility Report 10 Corporate Responsibility Commitment 2030 Corporate Responsibility Goals Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Introduction Cross-Cutting Commitments ESG matters receive strategic guidance and oversight at the highest levels of the company, including Baxter’s Chairman and Chief Executive Officer, Baxter’s Executive Leadership Team (formerly known as Senior Leader - ship Team) and the Board. BOARD OF DIRECTORS OVERSIGHT Baxter’s Board of Directors plays a critical role in corporate responsibility oversight. The full Board is regularly updated on corporate responsibility matters (including a discussion of related goals and industry trends). The Board’s Quality, Compliance and Technology (QCT) Committee and Nominating, Corporate Governance & Public Policy (NCGPP) Committee share oversight for ESG-related matters. The QCT Committee provides oversight for issues related to environmental sustainability and compliance, while the NCGPP Committee provides oversight for other aspects of corporate responsibility, including charitable contributions, public policy, access to healthcare and other social and governance issues. CORPORATE RESPONSIBILITY STEERING COMMITTEE With the inauguration of the company’s 2030 Corporate Responsibility Commitment and Goals, we launched an executive cross-functional Corporate Responsibility Steering Committee to provide direction and oversight to our ESG initiatives and set and advance our corporate responsibility strategy and culture. The Committee meets quarterly to monitor policies, action plans and strategies as well as other matters of significance to the company’s reputation as a socially responsible organization. It provides guidance to Baxter’s Corporate Responsibility Council. CORPORATE RESPONSIBILITY COUNCIL Baxter’s Corporate Responsibility Council is composed of executives and subject matter experts from across the company. The Council meets quarterly and provides oversight to ensure high standards of accountability. The Council’s role is to: • Track progress toward our 2030 Corporate Respon- sibility Commitment and Goals and deliver regular progress updates to the Corporate Responsibility Steering Committee, select members of Baxter’s Executive Leadership Team and our Board of Directors • Solicit and review stakeholder input on Baxter’s corporate responsibility programs, priorities, goals and disclosure, as well as broader industry trends • Oversee and assign day-to-day ESG matters to a combination of personnel and work groups from our corporate responsibility, EHS&S, human resources, finance, investor relations, legal, communications, procurement, engineering and other teams, depending on the nature of the matter SENIOR LEADER ACCOUNTABILITY To drive further accountability, beginning in 2021, the individual performance assessment for our Senior Leadership Team (now our Executive Leadership Team) under our Annual Incentive Plan is determined in connection with an assessment of our performance against pre-established measures for strategic priorities, including those related to ESG. For example, these measures include: • Patient safety and quality, including product safety and quality systems • Best place to work, including diversity in the workforce, culture, talent, Baxter’s ACT: Activating Change Today initiative to fight racial injustice, and environmental, health and safety measures • Growth through innovation, including our ongoing digital transformation and innovative ecosystem Learn more. Corporate Governance Resources Visit Baxter’s Our Governance webpage for information and links related to: ` Corporate Governance Guidelines ` Board of Directors, Committees and Committee Charters ` Code of Conduct ` Securities Trading Policy ` Ethics and Compliance Helpline Our Ethics and Compliance webpage includes links to additional standards and policies for our employees and suppliers that help us drive a culture of integrity and ethical behavior. GOVERNANCE AND MANAGEMENT OF CORPORATE RESPONSIBILITY AT BAXTER* *As of March, 2022. Corporate Responsibility Governance and Management Chairman and CEO Corporate Responsibility Steering Committee Board of Directors Quality, Compliance and Technology Committee Nominating, Corporate Governance & Public Policy Committee Corporate Responsibility Council Co-Chairs VP, Environment, Health, Safety and Sustainability Senior Director, Global Community Relations Corporate Responsibility Council Members Corporate Responsibility Working Group SVP, Chief Accounting Officer and Controller SVP, Human Resources VP, Finance, Financial Planning and Analysis VP, Global Audit SVP, Chief Quality Officer VP, Investor Relations SVP, Global Communications SVP, Chief Supply Chain Officer General Manager, Medication Delivery and Acute Therapies President, Renal Care Chief Procurement Officer VP, Global Engineering and Manufacturing Strategy VP, Global Patient Safety VP, HR—Americas, GBUs, and Global Functions Deputy General Counsel and Chief Compliance Officer VP, National and Strategic Accounts Senior Director, Product Quality EVP and Chief Operating Officer EVP and Chief Financial Officer SVP and General Counsel SVP and Corporate Secretary